Panagora Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,878
| Closed | -$294K | – | 1394 |
|
|
2023
Q1 | $294K | Hold |
16,878
| – | – | ﹤0.01% | 1267 |
|
|
2022
Q4 | $156K | Buy |
16,878
+499
| +3% | +$4.65K | ﹤0.01% | 1392 |
|
|
2022
Q3 | $141K | Hold |
16,379
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q2 | $133K | Hold |
16,379
| – | – | ﹤0.01% | 1427 |
|
|
2022
Q1 | $199K | Hold |
16,379
| – | – | ﹤0.01% | 1463 |
|
|
2021
Q4 | $559K | Sell |
16,379
-6,532
| -29% | -$256K | ﹤0.01% | 1173 |
|
|
2021
Q3 | $1.1M | Hold |
22,911
| – | – | 0.01% | 922 |
|
|
2021
Q2 | $1.03M | Sell |
22,911
-5,056
| -18% | -$224K | 0.01% | 966 |
|
|
2021
Q1 | $1.35M | Sell |
27,967
-16,525
| -37% | -$860K | 0.01% | 900 |
|
|
2020
Q4 | $2.4M | Sell |
44,492
-5,614
| -11% | -$254K | 0.01% | 636 |
|
|
2020
Q3 | $1.85M | Sell |
50,106
-96,150
| -66% | -$3.57M | 0.01% | 684 |
|
|
2020
Q2 | $4.53M | Sell |
146,256
-172
| -0.1% | -$4.77K | 0.03% | 429 |
|
|
2020
Q1 | $4.04M | Hold |
146,428
| – | – | 0.03% | 402 |
|
|
2019
Q4 | $4.28M | Buy |
146,428
+1,645
| +1% | +$39.2K | 0.02% | 533 |
|
|
2019
Q3 | $2.77M | Hold |
144,783
| – | – | 0.01% | 637 |
|
|
2019
Q2 | $3.18M | Buy |
144,783
+130,812
| +936% | +$2.87M | 0.01% | 642 |
|
|
2019
Q1 | $286K | Hold |
13,971
| – | – | ﹤0.01% | 1586 |
|
|
2018
Q4 | $176K | Buy |
+13,971
| New | +$208K | ﹤0.01% | 1662 |
|
|
2017
Q1 | – | Sell |
-106,558
| Closed | -$913K | – | 2421 |
|
|
2016
Q4 | $913K | Sell |
106,558
-3,204
| -3% | -$27.4K | ﹤0.01% | 1230 |
|
|
2016
Q3 | $902K | Buy |
109,762
+72,287
| +193% | +$607K | ﹤0.01% | 1231 |
|
|
2016
Q2 | $301K | Buy |
37,475
+11,373
| +44% | +$91.2K | ﹤0.01% | 1528 |
|
|
2016
Q1 | $176K | Sell |
26,102
-170,947
| -87% | -$1.12M | ﹤0.01% | 1693 |
|
|
2015
Q4 | $1.55M | Buy |
197,049
+32,705
| +20% | +$240K | 0.01% | 899 |
|
|
2015
Q3 | $942K | Sell |
164,344
-1,094
| -0.7% | -$6.77K | 0.01% | 1054 |
|
|
2015
Q2 | $895K | Buy |
165,438
+20,943
| +14% | +$108K | ﹤0.01% | 1145 |
|
|
2015
Q1 | $675K | Buy |
144,495
+117,066
| +427% | +$509K | ﹤0.01% | 1211 |
|
|
2014
Q4 | $114K | Hold |
27,429
| – | – | ﹤0.01% | 1824 |
|
|
2014
Q3 | $143K | Sell |
27,429
-22,087
| -45% | -$113K | ﹤0.01% | 1737 |
|
|
2014
Q2 | $165K | Buy |
49,516
+14,699
| +42% | +$48.9K | ﹤0.01% | 1776 |
|
|
2014
Q1 | $121K | Buy |
34,817
+12,555
| +56% | +$47K | ﹤0.01% | 1884 |
|
|
2013
Q4 | $81K | Sell |
22,262
-15,778
| -41% | -$54.8K | ﹤0.01% | 1895 |
|
|
2013
Q3 | $114K | Buy |
+38,040
| New | +$107K | ﹤0.01% | 1830 |
|
Other funds holding NEO
GF
FLAM
Panagora Asset Management's NEO Position: Q2 2023 in Review
Panagora Asset Management sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 16,878 shares — an estimated $294K sold.
Panagora Asset Management first reported a position in NEO in Q3 2013 and held it in 32 quarters. The position peaked at $4.53M in Q2 2020. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2023.
- Panagora Asset Management reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
- Panagora Asset Management sold 16,878 NeoGenomics shares in Q2 2023, an estimated $294K.
- Panagora Asset Management first reported a position in NeoGenomics in Q3 2013 and held it in 32 quarters.
- Panagora Asset Management's NeoGenomics position peaked at $4.53M in Q2 2020.
- 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.
Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.